GWAS data revealed the association between FGFR2 genetic variants and the risk of breast cancer [72, 76], for instance, rs4752575 was shown to alter the expression of FGFR2 leading to the increased susceptibility to breast cancer [77]. Here, FGFR2 is linked to breast carcinoma.